NASDAQ: NBPNovabridge Biosciences Stock Ownership - Who owns Novabridge Biosciences?
Insider buying vs selling
Have Novabridge Biosciences insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Sean Wuxiong Cao | CXO | 2026-09-09 | 107,978 | $0.74 | $79.90kSell |
| Cong Claire Xu | EVP | 2026-08-31 | 3,282 | $0.79 | $2.59kSell |
| Cong Claire Xu | SVP Clinical Development | 2026-07-06 | 4,485 | $0.89 | $3.99kSell |
| Phillip Andrew Dennis | Chief Medical Officer | 2026-06-18 | 8,494 | $0.66 | $5.61kSell |
| Cong Claire Xu | SVP Clinical Development | 2026-06-01 | 3,494 | $3.94 | $13.77kSell |
| Sean Wuxiong Cao | Chief Business Development Officer and Director | 2026-05-14 | 21,399 | $1.99 | $42.58kSell |
| Mark Arnold Hagler | President and Chief Commercial Officer | 2026-04-24 | 230,000 | $2.51 | $577.30kBuy |
NBP insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when NBP insiders and whales buy or sell their stock.
NBP Shareholders
What type of owners hold Novabridge Biosciences stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Wei Fu | 11.43% | 30,499,699 | $49.71M | Insider |
| Xiaofan Neo Zhang | 0.33% | 874,000 | $1.42M | Insider |
| Cong Claire Xu | 0.11% | 304,201 | $495.85k | Insider |
| Sean Wuxiong Cao | 0.10% | 266,467 | $434.34k | Insider |
| Mark Arnold Hagler | 0.09% | 230,000 | $374.90k | Insider |
| Phillip Andrew Dennis | 0.06% | 157,941 | $257.44k | Insider |
| Xiyong Fu | 0.02% | 59,823 | $97.51k | Insider |
| Robert A. Lenz | 0.01% | 17,218 | $28.07k | Insider |
| Hhlrad | 0.00% | 5,981 | $9.75k | Institution |
| Hhlr Advisors Ltd | 0.00% | 5,980 | $9.75k | Institution |
NBP vs Biotech Stocks
Novabridge Biosciences Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.